tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Primary Graft Dysfunction D055031 1 associated lipids
Esophageal Perforation D004939 1 associated lipids
Epididymitis D004823 1 associated lipids
Pruritus Vulvae D011539 1 associated lipids
Central Serous Chorioretinopathy D056833 1 associated lipids
Feline Acquired Immunodeficiency Syndrome D016181 1 associated lipids
Budd-Chiari Syndrome D006502 1 associated lipids
AIDS-Associated Nephropathy D016263 1 associated lipids
Oral Ulcer D019226 1 associated lipids
Epidermolysis Bullosa Dystrophica D016108 1 associated lipids
Mutism D009155 1 associated lipids
Amyloid Neuropathies D017772 1 associated lipids
Cervical Intraepithelial Neoplasia D018290 1 associated lipids
Migraine with Aura D020325 1 associated lipids
Porokeratosis D017499 1 associated lipids
Lentigo D007911 1 associated lipids
Akinetic Mutism D000405 1 associated lipids
Sleep Apnea, Central D020182 1 associated lipids
Orchitis D009920 1 associated lipids
Phyllodes Tumor D003557 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Cho JH et al. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet. 2014 Eur J Pharm Sci pmid:24388864
Frassetto LA et al. Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients. 2014 Transplantation pmid:24389906
Lerut JP et al. Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study. 2014 Ann. Surg. pmid:25379858
Hitzler JK et al. Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. 2014 Pediatr Blood Cancer pmid:24391118
Wu Y et al. Increased macrophage activation inhibited by tacrolimus in the kidney of diabetic rats. 2014 Nephron Exp. Nephrol. pmid:25376933
Levitsky J and Feng S Sirolimus and mTOR inhibitors in liver transplantation: the wheel has come full circle. 2014 Am. J. Transplant. pmid:24620373
Catalano G et al. Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome. 2014 Transpl. Int. pmid:24606320
Zhang Y et al. Genome-wide identification and analysis of FK506-binding protein gene family in peach (Prunus persica). 2014 Gene pmid:24342662
Muhetaer G et al. Clinical significance of peripheral blood lymphocyte sensitivity to glucocorticoids for the differentiation of high-risk patients with decreased allograft function after glucocorticoid withdrawal in renal transplantation. 2014 Clin Ther pmid:25037282
Shin BH et al. Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. 2014 Transplantation pmid:24342979
Siddiqui A et al. Chemometric methods for the quantification of crystalline tacrolimus in solid dispersion by powder X-ray diffractrometry. 2014 J Pharm Sci pmid:24585357
Shivaswamy V et al. Tacrolimus and sirolimus have distinct effects on insulin signaling in male and female rats. 2014 Transl Res pmid:24361102
Uesugi S et al. Calcineurin inhibitors suppress the high-temperature stress sensitivity of the yeast ubiquitin ligase Rsp5 mutant: a new method of screening for calcineurin inhibitors. 2014 FEMS Yeast Res. pmid:25035868
Goldberg NR et al. Success with single-agent immunosuppression for multifocal choroidopathies. 2014 Am. J. Ophthalmol. pmid:25194229
Tavira B et al. [Pharmacogenetics of tacrolimus: from bench to bedside?]. 2014 Nefrologia pmid:24463861
Qin XL et al. Effect of Tacrolimus on the pharmacokinetics of bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) and the potential roles of CYP3A and P-gp. 2014 Phytomedicine pmid:24462213
Asrani SK et al. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. 2014 Am. J. Transplant. pmid:24456026
Oellerich M et al. Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation. 2014 Ther Drug Monit pmid:24452066
Wang J et al. Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients. 2014 Chin. Med. J. pmid:25316243
Suarez-Kurtz G et al. Pharmacogenomic implications of population admixture: Brazil as a model case. 2014 Pharmacogenomics pmid:24444410
Ducroux E et al. Hidradenitis suppurativa after renal transplantation: complete remission after switching from oral cyclosporine to oral tacrolimus. 2014 J. Am. Acad. Dermatol. pmid:25437996
Khorrami A et al. Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction. 2014 Daru pmid:25312839
Hu YM et al. Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor. 2014 J. Pharmacol. Exp. Ther. pmid:24610957
Bäckman L and Persson CA An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients. 2014 Ann. Transplant. pmid:24637379
Mai HL et al. IL-7 receptor blockade following T cell depletion promotes long-term allograft survival. 2014 J. Clin. Invest. pmid:24569454
Tokuoka H et al. Nurr1 expression is regulated by voltage-dependent calcium channels and calcineurin in cultured hippocampal neurons. 2014 Neurosci. Lett. pmid:24291696
Hancock WW Effects of histone deacetylase inhibitors on alloresponses. 2014 Lancet Oncol. pmid:24295573
Boran M et al. Determining renal resistive and pulsatility indexes long-term after kidney transplantation in kidney transplant recipients on cyclosporine a-, tacrolimus-, or sirolimus-based regimens. 2014 Transplant. Proc. pmid:24935296
Fuchs U et al. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus. 2014 Transpl. Immunol. pmid:24932812
Han N et al. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation. 2014 Basic Clin. Pharmacol. Toxicol. pmid:24238261
Taguchi K et al. False tacrolimus concentrations measured by antibody-conjugated magnetic immunoassay in liver transplant patient: 2 case reports and literature review. 2014 Exp Clin Transplant pmid:24206050
Zhang L et al. Ambrisentan improves the outcome of rats with liver transplantation partially through reducing nephrotoxicity. 2014 Eur Rev Med Pharmacol Sci pmid:25268107
Donnadieu B et al. Central retinal vein occlusion-associated tacrolimus after liver transplantation. 2014 Transplantation pmid:25955343
Rangel EB Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions. 2014 Expert Opin Drug Metab Toxicol pmid:25255841
Trotter JF and Lizardo-Sanchez L Everolimus in liver transplantation. 2014 Curr Opin Organ Transplant pmid:25254569
Rodríguez-Serrano M et al. Does the calcineurin inhibitor have influence on cytomegalovirus infection in heart transplantation? 2014 Clin Transplant pmid:24325305
Sharp WW et al. Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. 2014 FASEB J. pmid:24076965
Al-Harbi NO et al. Protection against tacrolimus-induced cardiotoxicity in rats by olmesartan and aliskiren. 2014 Toxicol. Mech. Methods pmid:25199528
Notaro E et al. Dose conversion factor between cyclosporine and tacrolimus in pediatric heart transplant recipients. 2014 J. Heart Lung Transplant. pmid:24854566
Lan CC et al. Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions. 2014 J Eur Acad Dermatol Venereol pmid:23301526
Sæves I et al. Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantation. 2014 Ther Drug Monit pmid:24081206
Burroughs LM et al. Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. 2014 Biol. Blood Marrow Transplant. pmid:25196857
Ghanem RC et al. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis. 2014 Cornea pmid:25188789
Cavalli RC et al. Analysis of the histology of the scar bladder and biochemical parameters of rats with a solitary kidney undergoing immunosuppression with tacrolimus. 2014 Acta Cir Bras pmid:25140592
Mabe S et al. Detecting protein-protein interactions based on kinase-mediated growth induction of mammalian cells. 2014 Sci Rep pmid:25135216
Sol Fustiñana M et al. Protein degradation by ubiquitin-proteasome system in formation and labilization of contextual conditioning memory. 2014 Learn. Mem. pmid:25135196
Hagihara Y et al. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease. 2014 J Crohns Colitis pmid:24011513
Kilinc S et al. The effects of preoperative immunosuppressive therapy on ischemia and reperfusion (I/R) injury in healthy rats. 2014 Int Urol Nephrol pmid:24014133
Gürkan A et al. Alpha 2 integrin gene (ITGA2) polymorphism in renal transplant recipients with and without drug induced gingival overgrowth. 2014 Arch. Oral Biol. pmid:24581850
Spasovski G and Masin-Spasovska J How to improve the survival of the kidney transplant - is it only the pharmaceutical management? 2014 Expert Opin Pharmacother pmid:24617949
Kim JS et al. Effects of FK-506 and CTLA4--Ig on nerve allografts in mice. 2014 J Plast Reconstr Aesthet Surg pmid:24120418
Wang B et al. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats. 2014 J Ethnopharmacol pmid:25091466
Bao J and Liang H Tacrolimus-induced permanent asymptomatic pontine myelinolysis after liver transplantation. 2014 Intern. Med. pmid:25088893
Purani JM and Purani HJ Treatment of geographic tongue with topical tacrolimus. 2014 BMJ Case Rep pmid:25085945
Kornblit B et al. A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation. 2014 Haematologica pmid:25085357
Verghese PS et al. Calcineurin inhibitors in HLA-identical living related donor kidney transplantation. 2014 Nephrol. Dial. Transplant. pmid:24414376
Da-Long S et al. Tacrolimus on Kimura's disease: a case report. 2014 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22939325
Kyriakou A et al. Therapeutic efficacy of topical calcineurin inhibitors in plasma cell balanitis: case series and review of the literature. 2014 Dermatology (Basel) pmid:24434685
Thapa RK and Yoo BK Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation. 2014 J Dermatolog Treat pmid:23210668
Viecelli A et al. Diagnostic and management dilemma of a pancreas-kidney transplant recipient with aplastic anaemia. 2014 BMJ Case Rep pmid:25257886
Yamazoe K et al. Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine. 2014 Cornea pmid:25255133
Segarra-Medrano A et al. Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus. 2014 Nefrologia pmid:25036063
John K et al. Role of dendritic cells in the context of acute cellular rejection: comparison between tacrolimus- or cyclosporine A-treated heart transplanted recipients. 2014 Cytometry B Clin Cytom pmid:24668729
Okamoto T et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with febrile urinary tract infection. 2014 Eur. J. Pediatr. pmid:24221606
Steinebrunner N et al. Reduced residual gene expression of nuclear factor of activated T cells-regulated genes correlates with the risk of cytomegalovirus infection after liver transplantation. 2014 Transpl Infect Dis pmid:24666466
Dessilly G et al. ABCB1 1199G>A genetic polymorphism (Rs2229109) influences the intracellular accumulation of tacrolimus in HEK293 and K562 recombinant cell lines. 2014 PLoS ONE pmid:24621983
Terada Y et al. Intestinal P-glycoprotein expression is multimodally regulated by intestinal ischemia-reperfusion. 2014 J Pharm Pharm Sci pmid:24934555
Mai S et al. In vitro and in vivo release characteristics of Tacrolimus (FK506) from an episcleral drug-delivery implant. 2014 J Ocul Pharmacol Ther pmid:24933028
Urbanowicz T et al. Comparison of conventional tacrolimus versus prolong release formula as initial therapy in heart transplantation. 2014 Ann. Transplant. pmid:24949728
Nomura H et al. A patient with lupus miliaris disseminatus faciei treated successfully with a combination of oral metronidazole and topical tacrolimus. 2014 J. Dermatol. pmid:24931738
Fuchs U et al. Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus. 2014 Ann. Transplant. pmid:24953848
Rahman Z et al. Near-infrared and fourier transform infrared chemometric methods for the quantification of crystalline tacrolimus from sustained-release amorphous solid dispersion. 2014 J Pharm Sci pmid:24931728
Elamin S et al. Co-administration of ketoconazole and tacrolimus to kidney transplant recipients: cost minimization and potential metabolic benefits. 2014 Saudi J Kidney Dis Transpl pmid:24969193
Gibbs BF et al. Highly specific targeting of human leukocytes using gold nanoparticle-based biologically active conjugates. 2014 J Biomed Nanotechnol pmid:24804546
Richards KR et al. Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. 2014 Transplantation pmid:24784360
Cutler C et al. Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. 2014 Blood pmid:24982504
Liu Z et al. Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review. 2014 PLoS ONE pmid:25198195
Katayama M et al. Preliminary study of interaction of clarithromycin with tacrolimus in cats. 2014 J. Vet. Med. Sci. pmid:25099737
Tran D et al. Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature. 2014 Exp Clin Transplant pmid:24844288
Kahvecioglu S et al. Effects of calcineurin inhibitors on paraoxonase and arylesterase activity after a kidney transplant. 2014 Exp Clin Transplant pmid:24447269
Marin-Casino M et al. Significant tacrolimus and dronedarone interaction in a kidney transplant recipient. 2014 Transplantation pmid:25243519
Kalkan G et al. An alternative treatment model: the combination therapy of narrow band ultraviolet B phototherapy and tacrolimus ointment 0.1% in biphasic amyloidosis. 2014 J Pak Med Assoc pmid:25272550
Chamienia A et al. Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results. 2014 Transplant. Proc. pmid:25380901
Doren EL and Aya-ay ML Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids. 2014 Aesthet Surg J pmid:24448967
Lin YH and Pratt MR A dual small-molecule rheostat for precise control of protein concentration in Mammalian cells. 2014 Chembiochem pmid:24615791
Abe T et al. Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation. 2014 Transplant. Proc. pmid:24767367
Mita A et al. Optimal initial dose of orally administered once-daily extended-release tacrolimus following intravenous tacrolimus therapy after liver transplantation. 2014 Transplant. Proc. pmid:24767351
Jin L et al. Dipeptidyl peptidase IV inhibitor MK-0626 attenuates pancreatic islet injury in tacrolimus-induced diabetic rats. 2014 PLoS ONE pmid:24959755
Hashi S et al. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients. 2014 Transplant. Proc. pmid:24767342
Uemoto S et al. Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan. 2014 Transplant. Proc. pmid:24767340
Zhang X et al. Profiling of drug binding proteins by monolithic affinity chromatography in combination with liquid chromatography-tandem mass spectrometry. 2014 J Chromatogr A pmid:25064533
Borda B et al. Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation. 2014 Acta Physiol Hung pmid:25183511
Chen C et al. Rapid construction of a Bacterial Artificial Chromosomal (BAC) expression vector using designer DNA fragments. 2014 Plasmid pmid:25454071
Momohara S et al. Recent trends in orthopedic surgery aiming to improve quality of life for those with rheumatoid arthritis: data from a large observational cohort. 2014 J. Rheumatol. pmid:24692532
Lin Q et al. Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus. 2014 J. Invest. Dermatol. pmid:24682043
Díaz-García C et al. Pregnancy after allogeneic uterus transplantation in the rat: perinatal outcome and growth trajectory. 2014 Fertil. Steril. pmid:25439799
Tsunashima D et al. Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study. 2014 Clin Ther pmid:24680768
Ibrahim O et al. The role of infliximab in the treatment of superficial granulomatous pyoderma of the head and neck. 2014 J. Am. Acad. Dermatol. pmid:25438004
Kraaij MD et al. Human monocytes produce interferon-gamma upon stimulation with LPS. 2014 Cytokine pmid:24680476
Sawamoto K et al. Mechanisms of lower maintenance dose of tacrolimus in obese patients. 2014 Drug Metab. Pharmacokinet. pmid:24670405